PharmaShots | Incisive News in 3 Shots

Subscribe Now

Tot Biopharm

Insights+ Key Biosimilars Events of December 2021

Insights+ Key Biosimilars Events of December 2021

January 6, 2022

Tot Biopharm’s Pusintin (biosimilar, bevacizumab) Receives NMPA’s Marketing Approval for Non-Squamous NSCLC and Metastatic Colorectal Cancer

Tot Biopharm’s Pusintin (biosimilar, bevacizumab) Receives NMPA’s Marketing Approval for Non-Squamous NSCLC and Metastatic Colorec...

December 1, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us